查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1837172

尿失禁治療設備市場按設備類型、材料、技術、性別、形態、年齡層、應用、最終用戶和分銷管道分類－全球預測，2025-2032年

Urinary Incontinence Device Market by Device Type, Material, Technology, Gender, Form, Age Group, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，尿失禁治療設備市場規模將達到 62.2 億美元，複合年成長率為 7.60%。

關鍵市場統計數據
基準年2024年 34.6億美元
預計年份：2025年 37.1億美元
預測年份 2032 62.2億美元
複合年成長率 (%) 7.60%

為指南尿失禁治療設備相關人員，制定一個涵蓋未滿足的臨床需求、不斷變化的患者期​​望和多學科優先事項的策略框架。

本執行摘要首先聚焦於尿失禁醫療器材市場，重點闡述了臨床負擔、不斷變化的患者期​​望以及應指南行業相關人員的策略重點。尿失禁不分年齡和性別，臨床表現多樣，需要各種保守治療、微創治療和植入式治療方案。在整個治療過程中，臨床醫生都在尋求兼顧療效、患者舒適度和長期耐用性的器械，而採購和支付相關人員則越來越關注可驗證的療效和成本效益。

鑑於醫療器材創新日新月異，以及材料科學和數位醫療領域的同步發展，製造商和投資者必須以多學科視角審視產品開發。臨床證據的產生、監管合規和報銷途徑共同建構了永續推廣的框架。在此背景下，將可靠的臨床檢驗與可擴展的生產製造和差異化的分銷策略相結合的綜合方法至關重要。因此，引言部分概述了可透過策略重點釋放價值的關鍵領域，包括技術差異化、終端用戶協作和彈性供應鏈設計，從而為本摘要的其餘部分奠定了基礎。

技術、人口結構和監管方面的變革性變化將重新定義尿失禁治療設備的競爭優勢和市場推廣路徑。

在技​​術、人口和政策等多面向因素的共同推動下，尿失禁治療器材領域正經歷多重變革。電刺激技術的進步、植入材料的改良以及機械部件的微型化，在提升器械性能的同時，也提高了病患的舒適度。同時，遠端監測的興起以及與行動醫療平台的整合，使得長期用藥依從性追蹤和對真實世界療效的了解成為可能，這也為基於循證醫學的醫保報銷提供了有力支持。

從人口結構來看，人口老化和對提升生活品質干預措施的廣泛需求，正推動可靠、易用解決方案的臨床應用。監管機構也正在調整核准流程，力求在確保患者及時獲得治療的同時，兼顧嚴格的安全評估，鼓勵企業投資上市後監測和真實世界證據策略。此外，供應鏈韌性如今已成為管理層關注的焦點，促使企業重新評估對單一供應商的依賴，並推動了關於近岸外包的討論。總而言之，這些轉變正在重新定義競爭優勢。那些兼具卓越工程技術和數據主導成果、穩健的監管規劃以及敏捷的供應鏈能力的企業，很可能引領下一波應用浪潮。

2025年實施的關稅政策變化將如何重塑泌尿失禁醫療器材價值鏈的採購、籌資策略和商業化動態？

2025年美國關稅調整的累積影響將對尿失禁醫療器材生態系統產生重大影響，尤其是對那些依賴跨境供應鏈取得零件、成品和特殊材料的製造商而言。關稅負擔的增加將推高投入成本，擠壓製造商的淨利率，並可能促使他們重新思考籌資策略。為此，採購團隊可能會尋求透過近岸外包、雙重採購和重新談判供應商合約來降低風險並保護利潤。

除了直接的成本影響外，關稅還可能影響產品設計和材料選擇的策略決策，促使開發商轉向替代方案，以減少對受關稅影響的進口產品的依賴。經銷商和醫療保健機構可能面臨價格調整，這可能會延遲對成本敏感的領域（例如長期照護機構和門診中心）的採購週期。同時，政策變化也可能為國內製造業的投資創造機會，從而縮短前置作業時間並提高品質監管水準。在臨床方面，相關人員必須保持警惕，確保以成本主導的材料替代不會損害設備的安全性或性能，並確保監管文件反映設計和供應鏈的變化。總而言之，關稅會促進更廣泛的供應鏈轉型，迫使相關人員調整籌資策略、臨床檢驗和商業計劃，以維護產品的可及性和價值。

將設備類型、材料選擇、技術模式、患者人口統計特徵和分銷管道與臨床應用和商業策略聯繫起來的綜合細分洞察

關鍵的細分洞察揭示了產品設計、材料科學、技術模式、目標族群、使用模式和通路偏好如何相互交織，共同塑造臨床應用和市場機會。從器械類型來看，市場分為體外器械和體內器械，體外器械包括導尿管、收集器、輸液收集器和陰莖夾，體內器械包括人工尿道括約肌、子宮托、薦椎神經刺激裝置、尿道植入物和陰道吊帶。關於材料選擇，報告強調了乳膠、聚合物基材料和矽膠的重要性。

技術細分將電刺激設備與機械設備和外科植入分開來，從而影響臨床試驗設計和外科醫生培訓路徑。性別特異性方法仍然至關重要，因為女性和男性患者的解剖結構和病因特徵不同，這會影響設備的選擇和治療結果。區分拋棄式產品產品和可重複使用產品的外形規格會影響採購週期、消毒需求和環境永續性考量。成人和兒童族群的不同年齡層需要進行客製化的安全性和可用性測試。將臨床用途分為功能性尿失禁、溢出性尿失禁、壓力性尿失禁和急迫性尿失禁，既決定了產品規格，也決定了臨床終點。最後，終端用戶（門診手術中心、家庭護理機構、醫院/診所和長期護理機構）與分銷管道偏好（醫院藥房、線下藥房和線上銷售）的交集，決定了面向消費者的銷售管道策略和售後支援需求。

美洲、歐洲、中東和非洲以及亞太地區的區域動態將影響監管策略、報銷調整和分銷重點。

區域動態對法規環境、報銷系統和供應鏈架構有顯著影響，進而決定企業如何優先投資以及如何調整其市場進入策略。在美洲，市場參與企業面臨著多元化的支付方和高度的臨床專業化，通常需要清晰的療效數據、有針對性的關鍵意見領袖（KOL）互動以及彈性價格設定框架。放眼歐洲、中東和非洲，相關人員會遇到不同的監管要求和報銷標準，而各國的具體路徑和區域特定的臨床證據則推動產品的推廣應用。在這些地區的大部分地區，與當地經銷商夥伴關係以及對採購週期進行謹慎管理對於市場准入至關重要。

亞太地區的特徵是人口結構快速變化、監管成熟度差異顯著以及製造業能力不斷提升。該地區不斷發展的醫療基礎設施，以及對微創療法的日益重視，為新產品的引入創造了機遇，而本地化的製造能力則能帶來成本優勢和供應鏈韌性。由於亞太地區各地終端使用者行為、臨床實踐模式以及數位化醫療應對力存在差異，企業需要採取精細的商業策略，使產品設計、臨床證據產生和經銷夥伴與當地相關人員的期望相契合。

競爭格局、合作模式和創新管道正在塑造尿失禁治療領域的領導地位和長期差異化優勢。

在尿失禁醫療器材領域，各公司之間的競爭格局持續演變，其驅動力包括產品創新、策略夥伴關係和差異化的商業化模式。領先企業正投資於模組化設計策略，以實現迭代改進，同時保持監管的連續性。醫療器材製造商與數位醫療服務提供者之間的合作正在加速整合解決方案的開發，這些解決方案將機械療法和植入式療法與遠端監測和依從性平台相結合，從而增強了對支付方和醫療服務提供方的價值提案。

併購和策略聯盟仍然是擴大規模的重要途徑，尤其是在能夠整合互補的產品組合和地理佈局以最佳化臨床支援和分銷的情況下。圍繞新型材料、刺激演算法和微創給藥系統所建構的智慧財產權組合是關鍵的競爭優勢。同時，專注於創新的小型參與企業正在積極研發差異化產品，他們通常會利用針對特定適應症的臨床項目來驗證產品價值，然後再尋求更廣泛的應用。對於商業性領導者而言，產品差異化、證據產生和通路策略之間的相互作用將決定哪些公司能夠獲得持續的市場領導地位。

醫療設備開發商和商業團隊應優先採取行動，協調產品設計、證據產生和供應鏈彈性，以實現持續的競爭優勢。

為了獲得永續的競爭優勢，產業領導者應制定一系列切實可行的優先事項，將產品設計、臨床檢驗、商業性執行和供應鏈韌性有機結合起來。首先，優先考慮可製造性設計和以使用者為中心的人體工學，以降低整體擁有成本，同時提高患者依從性和臨床醫生的接受度。其次，將可靠的真實世界證據計畫納入產品生命週期，以支持報銷談判，並展示產品在不同醫療環境中的長期療效。第三，透過供應商多元化和考慮關鍵零件的近岸外包，減輕關稅和物流中斷的影響。

第四，制定針對門診手術中心、長期照護機構和家庭照護服務提供者的推廣計劃，提供每位最終使用者獨特工作流程的培訓和支援。第五，與數位醫療服務提供者建立策略夥伴關係關係，以實現遠端監測和結果追蹤，從而增強支付方的價值提案。第六，在產品上市初期就調整監管策略，預測上市後監理要求，並儘可能設計符合多個司法管轄區要求的研究。最後，將永續性因素納入產品生命週期規劃，在環境影響和成本結構之間權衡一次性使用和可重複使用方案。這些建議旨在指導領導者進行重點投資，以提高產品採用率、管理風險並支持可擴展的成長。

我們採用了一種嚴謹的混合方法研究途徑，結合了主要相關人員訪談、臨床文獻綜合和三角證據檢驗，為策略決策提供資訊。

本執行摘要的調查方法結合了對主要臨床文獻的結構化回顧、對關鍵臨床和商業相關人員的定性訪談，以及對監管和研發資訊的系統分析。主要資訊來源包括與泌尿系統和婦科臨床醫生、醫院和長期護理網路的採購負責人以及產品開發專家的深入對話，以確保結論能夠反映技術、臨床和商業性觀點。次要分析則納入了同行評審期刊、監管指導文件、產品標籤和公司發布的臨床試驗摘要，以檢驗臨床性能描述。

數據綜合運用三角測量技術來協調不同的輸入數據，並突顯共識領域和新出現的爭議。細分框架與臨床路徑和最終用戶工作流程相匹配，以驗證其對商業化決策的實際意義。品管包括將訪談見解與已記錄的證據進行交叉檢驗，以及反覆的專家評審。對於仍存在不確定性的領域，調查方法會指出需要進一步進行針對性研究的主題，例如不同植入材料的長期療效或耐久性比較。這種方法有助於對趨勢進行可靠的解讀，同時也能辨識出需要更深入研究的領域。

一項著眼於未來的整合計劃，強調創新、循證實踐和供應鏈韌性的策略協同，以最大限度地造福患者並實現商業性成功。

總之，尿失禁醫療器材領域正處於曲折點對於應對醫療設備實施的複雜性以及在不同醫療機構中擴大應用至關重要。

展望未來，相關人員應著重關注以下幾個面向：產生高品質的結果數據、最大限度地減少供應鏈中斷風險，以及設計能夠解決病患和醫護人員特定痛點的產品。有了這些優先事項，該行業就能繼續提供改善生活品質的解決方案，同時滿足現代醫療保健系統日益成長的期望。這個結論強調了深思熟慮的策略和嚴謹的執行對於掌握發展動能、推動永續成長的重要性。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將人工智慧演算法整合到智慧型穿戴式尿失禁感測器中，用於即時監測漏尿情況
  • 微創神經調控植入在治療頑固性尿失禁的應用日益廣泛
  • 設備製造商與遠端醫療平台合作，拓展遠距尿失禁護理服務
  • 開發針對不同性別的骨盆底裝置，以適應男性和女性患者之間的解剖結構差異
  • 為了解決消費者永續性的擔憂，可生物分解和環保吸收性產品正在興起。
  • 監管部門核准加速新型膀胱灌注療法治療應力性尿失禁的市場准入
  • 泌尿系統診所與數位醫療公司建立策略合作夥伴關係，以加強患者依從性追蹤
  • 對採用生物回饋療法技術的家用骨盆底肌訓練系統的投資激增
  • 拓展電子商務管道，以推廣失禁護理產品的個人化訂閱模式
  • 超音波填充劑輸送系統的出現提高了尿道注射手術的準確性

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依設備類型分類的尿失禁設備市場

  • 外部設備
    • 導管
    • 收藏家和滴水收藏家
    • 陰莖夾
  • 內部設備
    • 人工尿道括約肌
    • 子宮托
    • 薦骨神經刺激器
    • 尿道插入器
    • 陰道吊帶

9. 依材料分類的尿失禁器材市場

  • 乳膠
  • 聚合物基材料
  • 矽酮

第10章 按技術分類的尿失禁設備市場

  • 電刺激設備
  • 機械設備
  • 外科植入

11. 尿失禁治療設備市場－性別

  • 女士
  • 男性

第12章 尿失禁治療設備市場（依類型分類）

  • 一次性的
  • 可重複使用的

第13章 依年齡層別分類的尿失禁器械市場

  • 成人
  • 孩子們

第14章 依應用分類的尿失禁器材市場

  • 功能性尿失禁
  • 溢出性尿失禁
  • 應力性尿失禁
  • 急性尿失禁

第15章 依最終用戶分類的尿失禁設備市場

  • 門診手術中心
  • 居家照護環境
  • 醫院和診所
  • 長期照護機構

第16章 尿失禁器械市場（依通路分類）

  • 醫院藥房
  • 線下藥房
  • 線上銷售

17. 各地區尿失禁治療設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第18章 尿失禁器材市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第19章 各國尿失禁治療設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第20章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Aeroflow Inc.
    • Amber Therapeutics
    • Attends Healthcare Products, Inc. by Domtar Corporation
    • Avanos Medical, Inc.
    • Avation Medical
    • B. Braun SE
    • Becton, Dickinson and Company
    • BioDerm, Inc.
    • Boston Scientific Corporation
    • Caldera Medical
    • Coloplast A/S
    • Contipi Medical
    • ConvaTec Group PLC
    • Essity AB
    • Hollister Incorporated
    • Johnson & Johnson Services Inc.
    • Kimberly-Clark Corporation
    • Laborie
    • Life360 Innovation, Inc.
    • Medtronic PLC
    • Olympus Corporation
    • Ontex Group NV
    • Pelvital USA Inc.
    • PROMEDON GmbH
    • Styker Corporation
    • Teleflex Incorporated
    • Watkins-Conti Products, Inc.
Product Code: MRR-034B50030353

The Urinary Incontinence Device Market is projected to grow by USD 6.22 billion at a CAGR of 7.60% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.46 billion
Estimated Year [2025] USD 3.71 billion
Forecast Year [2032] USD 6.22 billion
CAGR (%) 7.60%

A strategic framing of clinical unmet needs, evolving patient expectations, and the multidisciplinary priorities that should guide urinary incontinence device stakeholders

This executive summary opens with a focused introduction to the urinary incontinence device landscape, emphasizing the clinical burden, evolving patient expectations, and the strategic priorities that should guide industry stakeholders. The condition transcends age and gender boundaries, creating heterogeneous clinical presentations that demand a mix of conservative, minimally invasive, and implantable solutions. Across care pathways, clinicians seek devices that balance efficacy with patient comfort and long-term durability, while procurement and payer stakeholders increasingly value demonstrable outcomes and cost-effectiveness.

Given the rapid pace of device innovation and parallel advances in materials science and digital health, manufacturers and investors must view product development through a multidisciplinary lens. Clinical evidence generation, regulatory alignment, and reimbursement pathways together create the framework for sustainable adoption. In this context, an integrated approach that couples robust clinical validation with scalable manufacturing and differentiated distribution strategies will be essential. The introduction thus frames the rest of this summary by outlining the key domains where strategic focus can unlock value, including technology differentiation, targeted end-user engagement, and resilient supply chain design.

Transformative technological, demographic, and regulatory shifts that are redefining competitive advantage and adoption pathways for urinary incontinence devices

The landscape for urinary incontinence devices is undergoing several transformative shifts driven by converging technological, demographic, and policy forces. Advances in electrical stimulation, refinement of implantable materials, and miniaturization of mechanical components are elevating device performance while improving patient comfort. Concurrently, the rise of remote monitoring and integration with mobile health platforms is enabling longitudinal adherence tracking and real-world outcome capture, which in turn supports evidence-based reimbursement discussions.

Demographically, an aging population and broader demand for quality-of-life interventions are increasing the clinical imperative for reliable, user-friendly solutions. Regulatory agencies are also adapting pathways to balance timely patient access with rigorous safety evaluation, encouraging companies to invest in post-market surveillance and real-world evidence strategies. Moreover, supply chain resilience has moved to the top of executive agendas, prompting re-evaluation of single-source dependencies and fostering nearshoring conversations. Taken together, these shifts are redefining competitive advantage: companies that pair engineering excellence with data-driven outcomes, robust regulatory planning, and supply chain agility will lead the next wave of adoption.

How tariff policy shifts enacted in 2025 are reshaping sourcing, procurement strategy, and commercialization dynamics across the urinary incontinence device value chain

The cumulative impact of United States tariff changes implemented in 2025 presents material implications for the urinary incontinence device ecosystem, particularly for manufacturers that rely on cross-border supply chains for components, finished goods, or specialized materials. Increased tariff burdens can raise input costs, compress manufacturer margins, and prompt reconsideration of sourcing strategies. In response, procurement teams are likely to pursue nearshoring, dual sourcing, and renegotiated supplier contracts to mitigate exposure and preserve margin integrity.

Beyond direct cost effects, tariffs can influence strategic decision-making around product design and material selection, nudging developers toward alternatives that reduce reliance on tariff-affected imports. Distributors and healthcare providers may face pricing adjustments, which could slow purchasing cycles in cost-sensitive segments such as long-term care facilities and ambulatory centers. At the same time, policy shifts can create opportunities for domestic manufacturing investment, with potential to shorten lead times and improve quality oversight. Clinically, stakeholders must remain vigilant to ensure that cost-driven material substitutions do not compromise device safety or performance, and that regulatory filings reflect any design or supply chain changes. In sum, tariffs act as a catalyst for broader supply chain transformation, compelling stakeholders to align procurement strategy, clinical validation, and commercial planning to preserve access and value.

Integrated segmentation insights linking device type, material selection, technology modality, patient demographics, and distribution channels to clinical adoption and commercial strategy

Key segmentation insights reveal how product design, material science, technology modality, demographic targeting, usage patterns, and channel preferences intersect to shape clinical adoption and commercial opportunity. When devices are considered by type, the market divides between External Devices and Internal Devices, with External Devices encompassing catheters, collectors and drip collectors, and penile clamps while Internal Devices include artificial urinary sphincters, pessaries, sacral nerve stimulation devices, urethral inserts, and vaginal slings. Consideration of material choices highlights the continuing relevance of latex alongside polymer-based materials and silicone, each carrying distinct implications for biocompatibility, patient comfort, and manufacturing processes.

Technological segmentation separates electrical stimulation devices from mechanical devices and surgical implants, prompting differentiated clinical trial designs and surgeon training pathways. Gender-specific approaches remain essential, as female and male patients present differing anatomical and etiological profiles that influence device selection and outcomes. Form factors that distinguish disposable from reusable products affect procurement cycles, sterilization requirements, and environmental sustainability considerations. Age-group segmentation across adults and pediatric populations requires tailored safety and usability testing. Clinical application categorization into functional incontinence, overflow incontinence, stress incontinence, and urge continence drives both product specifications and clinical endpoints. Finally, end-user distinctions among ambulatory surgical centers, homecare settings, hospitals and clinics, and long-term care facilities intersect with distribution channel preferences, including hospital pharmacies, offline pharmacies, and online sales, to define route-to-customer strategies and post-market support requirements.

Regional dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific that determine regulatory strategy, reimbursement alignment, and distribution prioritization

Regional dynamics exert a strong influence on regulatory environments, reimbursement systems, and supply chain architectures, shaping how companies prioritize investments and tailor go-to-market approaches. In the Americas, market participants face diverse payer landscapes and a high level of clinical specialization, which often necessitates clear outcome data, targeted KOL engagement, and flexible pricing frameworks. Moving across Europe, Middle East & Africa, stakeholders encounter a mosaic of regulatory requirements and reimbursement norms, where country-specific pathways and localized clinical evidence play decisive roles in adoption. In many parts of this region, partnerships with regional distributors and careful navigation of procurement cycles are critical to market entry.

Asia-Pacific presents a combination of rapid demographic change, varied regulatory maturity, and growing manufacturing capacity. The region's evolving healthcare infrastructure and rising emphasis on minimally invasive options create opportunities for novel device introductions, while local production capabilities can offer cost advantages and supply chain resilience. Across all regions, differences in end-user behavior, clinical practice patterns, and digital health readiness require that companies adopt a regionally nuanced commercial strategy that aligns product design, clinical evidence generation, and distribution partnerships with local stakeholder expectations.

Competitive dynamics, partnership models, and innovation pipelines that shape leadership trajectories and long-term differentiation in urinary incontinence therapeutics

Competitive dynamics among companies active in the urinary incontinence device arena continue to evolve, driven by product innovation, strategic partnerships, and differentiated commercialization models. Leading firms are investing in modular design strategies that enable iterative improvements while preserving regulatory continuity. Collaboration between device manufacturers and digital health providers is accelerating the development of integrated solutions that pair mechanical or implantable therapies with remote monitoring and adherence platforms, strengthening value propositions for payers and providers.

Mergers and strategic alliances remain an important route to scale, particularly where complementary portfolios or geographic footprints can be combined to optimize clinical support and distribution networks. Intellectual property portfolios centered on novel materials, stimulation algorithms, and minimally invasive delivery systems are important competitive moats. At the same time, smaller, innovation-focused entrants are contributing to an active pipeline of differentiated approaches, often leveraging focused clinical programs to prove value in niche indications before pursuing broader adoption. For commercial leaders, the interplay between product differentiation, evidence generation, and channel strategy will determine which companies achieve sustained market leadership.

Actionable priorities for device developers and commercial teams to synchronize product design, evidence generation, and supply resilience for sustained competitive advantage

Industry leaders should pursue a set of actionable priorities that align product design, clinical validation, commercial execution, and supply chain resilience to capture durable advantage. First, prioritize design-for-manufacturability and user-centric ergonomics to reduce total cost of ownership while improving patient adherence and clinician acceptance. Second, integrate robust real-world evidence plans into product lifecycles to support reimbursement negotiations and demonstrate longitudinal outcomes in diverse care settings. Third, diversify supplier bases and consider nearshoring for critical components to mitigate tariff exposure and logistical disruptions.

Fourth, develop targeted engagement programs for ambulatory surgical centers, long-term care facilities, and homecare providers, calibrating training and support to the unique workflows of each end user. Fifth, pursue strategic partnerships with digital health providers to enable remote monitoring and outcome tracking that strengthen payer value propositions. Sixth, align regulatory strategies early in development, anticipating post-market surveillance requirements and designing studies that satisfy multiple jurisdictions when feasible. Finally, embed sustainability considerations into product lifecycle planning, balancing disposable and reusable options against environmental impact and cost structures. These recommendations collectively guide leaders to make focused investments that improve adoption, manage risk, and support scalable growth.

A rigorous mixed-methods research approach that blends primary stakeholder interviews, clinical literature synthesis, and triangulated evidence validation to inform strategic decision-making

The research methodology underpinning this executive summary combined a structured review of primary clinical literature, qualitative interviews with key clinical and commercial stakeholders, and systematic analysis of regulatory and policy developments. Primary inputs included in-depth conversations with clinicians across urology and gynecology, procurement leaders from hospitals and long-term care networks, and product development experts, ensuring that technical, clinical, and commercial perspectives informed the conclusions. Secondary analysis incorporated peer-reviewed journals, regulatory guidance documents, product labeling, and company-published clinical trial summaries to validate clinical performance narratives.

Data synthesis employed triangulation techniques to reconcile divergent inputs and highlight consensus areas versus emerging debates. Segmentation frameworks were mapped to clinical pathways and end-user workflows to ensure practical relevance for commercialization decision-making. Quality control included cross-validation of interview insights against documented evidence and iterative review cycles with subject-matter experts. Where uncertainties remained, the methodology flagged topics that require further targeted study, such as long-term comparative effectiveness and durability across differing implantable materials. This approach supports confident interpretation of trends while acknowledging areas that demand deeper investigation.

A forward-looking synthesis emphasizing the strategic alignment of innovation, evidence generation, and supply resilience to maximize patient benefit and commercial success

In conclusion, the urinary incontinence device environment is at an inflection point where technological advances, changing payer expectations, and supply chain realignment converge to create both challenges and opportunities. Companies that align product innovation with pragmatic evidence strategies, resilient sourcing, and tailored regional execution will be well positioned to translate clinical capability into meaningful patient impact. Cross-functional collaboration across clinical, regulatory, and commercial teams is essential to navigate the complexities of device introduction and scale adoption across diverse care settings.

Moving forward, stakeholder attention should focus on generating high-quality outcome data, minimizing exposure to supply chain disruptions, and designing products that address specific patient and provider pain points. With these priorities in place, the sector can continue to deliver solutions that improve quality of life while meeting the rigorous expectations of modern healthcare systems. The conclusion underscores the importance of deliberate strategy and disciplined execution to capitalize on momentum and drive sustainable growth.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI algorithms in smart wearable incontinence sensors for real-time leakage monitoring
  • 5.2. Rising adoption of minimally invasive nerve modulation implants for refractory urinary incontinence management
  • 5.3. Collaboration between device manufacturers and telehealth platforms to expand remote continence care services
  • 5.4. Development of gender-specific pelvic floor devices tailored to anatomical differences in male and female patients
  • 5.5. Growth in biodegradable and eco-friendly absorbent products to address sustainability concerns among users
  • 5.6. Regulatory approvals accelerating market entry of novel bladder instillation therapies for stress incontinence
  • 5.7. Strategic partnerships between urology clinics and digital health firms to enhance patient adherence tracking
  • 5.8. Investment surge in at-home pelvic floor muscle training systems with integrated biofeedback technology
  • 5.9. Expansion of e-commerce channels driving personalized subscription models for continence care supplies
  • 5.10. Emergence of ultrasound-guided bulking agent delivery systems improving precision in urethral injection procedures

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Urinary Incontinence Device Market, by Device Type

  • 8.1. External Devices
    • 8.1.1. Catheters
    • 8.1.2. Collectors & Drip Collectors
    • 8.1.3. Penile Clamps
  • 8.2. Internal Devices
    • 8.2.1. Artificial Urinary Sphincters
    • 8.2.2. Pessaries
    • 8.2.3. Sacral Nerve Stimulation Devices
    • 8.2.4. Urethral Inserts
    • 8.2.5. Vaginal Slings

9. Urinary Incontinence Device Market, by Material

  • 9.1. Latex
  • 9.2. Polymer-based Materials
  • 9.3. Silicone

10. Urinary Incontinence Device Market, by Technology

  • 10.1. Electrical Stimulation Devices
  • 10.2. Mechanical Devices
  • 10.3. Surgical Implants

11. Urinary Incontinence Device Market, by Gender

  • 11.1. Female
  • 11.2. Male

12. Urinary Incontinence Device Market, by Form

  • 12.1. Disposable
  • 12.2. Reusable

13. Urinary Incontinence Device Market, by Age Group

  • 13.1. Adult
  • 13.2. Pediatrics

14. Urinary Incontinence Device Market, by Application

  • 14.1. Functional Incontinence
  • 14.2. Overflow Incontinence
  • 14.3. Stress Incontinence
  • 14.4. Urge Continence

15. Urinary Incontinence Device Market, by End User

  • 15.1. Ambulatory Surgical Centers
  • 15.2. Homecare Settings
  • 15.3. Hospitals & Clinics
  • 15.4. Long-Term Care Facilities

16. Urinary Incontinence Device Market, by Distribution Channel

  • 16.1. Hospital Pharmacy
  • 16.2. Offline Pharmacy
  • 16.3. Online Sales

17. Urinary Incontinence Device Market, by Region

  • 17.1. Americas
    • 17.1.1. North America
    • 17.1.2. Latin America
  • 17.2. Europe, Middle East & Africa
    • 17.2.1. Europe
    • 17.2.2. Middle East
    • 17.2.3. Africa
  • 17.3. Asia-Pacific

18. Urinary Incontinence Device Market, by Group

  • 18.1. ASEAN
  • 18.2. GCC
  • 18.3. European Union
  • 18.4. BRICS
  • 18.5. G7
  • 18.6. NATO

19. Urinary Incontinence Device Market, by Country

  • 19.1. United States
  • 19.2. Canada
  • 19.3. Mexico
  • 19.4. Brazil
  • 19.5. United Kingdom
  • 19.6. Germany
  • 19.7. France
  • 19.8. Russia
  • 19.9. Italy
  • 19.10. Spain
  • 19.11. China
  • 19.12. India
  • 19.13. Japan
  • 19.14. Australia
  • 19.15. South Korea

20. Competitive Landscape

  • 20.1. Market Share Analysis, 2024
  • 20.2. FPNV Positioning Matrix, 2024
  • 20.3. Competitive Analysis
    • 20.3.1. Aeroflow Inc.
    • 20.3.2. Amber Therapeutics
    • 20.3.3. Attends Healthcare Products, Inc. by Domtar Corporation
    • 20.3.4. Avanos Medical, Inc.
    • 20.3.5. Avation Medical
    • 20.3.6. B. Braun SE
    • 20.3.7. Becton, Dickinson and Company
    • 20.3.8. BioDerm, Inc.
    • 20.3.9. Boston Scientific Corporation
    • 20.3.10. Caldera Medical
    • 20.3.11. Coloplast A/S
    • 20.3.12. Contipi Medical
    • 20.3.13. ConvaTec Group PLC
    • 20.3.14. Essity AB
    • 20.3.15. Hollister Incorporated
    • 20.3.16. Johnson & Johnson Services Inc.
    • 20.3.17. Kimberly-Clark Corporation
    • 20.3.18. Laborie
    • 20.3.19. Life360 Innovation, Inc.
    • 20.3.20. Medtronic PLC
    • 20.3.21. Olympus Corporation
    • 20.3.22. Ontex Group NV
    • 20.3.23. Pelvital USA Inc.
    • 20.3.24. PROMEDON GmbH
    • 20.3.25. Styker Corporation
    • 20.3.26. Teleflex Incorporated
    • 20.3.27. Watkins-Conti Products, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 17. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 19. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. EUROPE URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. MIDDLE EAST URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. ASIA-PACIFIC URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. ASEAN URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. GCC URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. EUROPEAN UNION URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. BRICS URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 34. G7 URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 35. NATO URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 36. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 37. URINARY INCONTINENCE DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 38. URINARY INCONTINENCE DEVICE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. URINARY INCONTINENCE DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY COLLECTORS & DRIP COLLECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY COLLECTORS & DRIP COLLECTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY COLLECTORS & DRIP COLLECTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY COLLECTORS & DRIP COLLECTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY COLLECTORS & DRIP COLLECTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY COLLECTORS & DRIP COLLECTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PENILE CLAMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PENILE CLAMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PENILE CLAMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PENILE CLAMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PENILE CLAMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PENILE CLAMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ARTIFICIAL URINARY SPHINCTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ARTIFICIAL URINARY SPHINCTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ARTIFICIAL URINARY SPHINCTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ARTIFICIAL URINARY SPHINCTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ARTIFICIAL URINARY SPHINCTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ARTIFICIAL URINARY SPHINCTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PESSARIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PESSARIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PESSARIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PESSARIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PESSARIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PESSARIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URETHRAL INSERTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URETHRAL INSERTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URETHRAL INSERTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URETHRAL INSERTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URETHRAL INSERTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URETHRAL INSERTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY VAGINAL SLINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY VAGINAL SLINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY VAGINAL SLINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY VAGINAL SLINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY VAGINAL SLINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY VAGINAL SLINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LATEX, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LATEX, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LATEX, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LATEX, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LATEX, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LATEX, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY POLYMER-BASED MATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY POLYMER-BASED MATERIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY POLYMER-BASED MATERIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY POLYMER-BASED MATERIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY POLYMER-BASED MATERIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY POLYMER-BASED MATERIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SILICONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SILICONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SILICONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SILICONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SILICONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MECHANICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MECHANICAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MECHANICAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MECHANICAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MECHANICAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MECHANICAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SURGICAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SURGICAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SURGICAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SURGICAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SURGICAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SURGICAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FEMALE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FEMALE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FEMALE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FEMALE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FEMALE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MALE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MALE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MALE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MALE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MALE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MALE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISPOSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISPOSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REUSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PEDIATRICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FUNCTIONAL INCONTINENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FUNCTIONAL INCONTINENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FUNCTIONAL INCONTINENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FUNCTIONAL INCONTINENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FUNCTIONAL INCONTINENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FUNCTIONAL INCONTINENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OVERFLOW INCONTINENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OVERFLOW INCONTINENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OVERFLOW INCONTINENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OVERFLOW INCONTINENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OVERFLOW INCONTINENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OVERFLOW INCONTINENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY STRESS INCONTINENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY STRESS INCONTINENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY STRESS INCONTINENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY STRESS INCONTINENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY STRESS INCONTINENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY STRESS INCONTINENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URGE CONTINENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URGE CONTINENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URGE CONTINENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URGE CONTINENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URGE CONTINENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URGE CONTINENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OFFLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OFFLINE PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OFFLINE PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OFFLINE PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OFFLINE PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OFFLINE PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 292. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 298. LATIN AMERICA URIN